Day: October 3, 2023

Research and emerging treatment in bone dysplasia

October 3, 2023

Amid ongoing discussions about the Achondroplasia drug Vosoritide in various media and community platforms, we recognize the diverse range of opinions within our community and respect everyone’s right to their views. Regarding public discourse, especially in the media, we encourage everyone to approach discussions with awareness and respect. Show respect for adults with these conditions […]

Read More